1999/584/EC: Commission Decision of 28 July 1999 on financial assistance from the Community for storage in France, Italy and the United Kingdom of antigen for production of foot-and-mouth disease vaccine (notified under document number C(1999) 2449) (Text with EEA relevance) (Only the English, French and Italien texts are authentic)
L 221/12 EN Official Journal of the European Communities 21. 8. 1999 COMMISSION DECISION of 28 July 1999 on financial assistance from the Community for storage in France, Italy and the United Kingdom of antigen for production of foot-and-mouth disease vaccine (notified under document number C(1999) 2449) (Only the English, French and Italien texts are authentic) (Text with EEA relevance) (1999/584/EC) THE COMMISSION OF THE EUROPEAN COMMUNITIES, HAS ADOPTED THIS DECISION: Having regard to the Treaty establishing the European Community, Having regard to Council Decision 90/424/EEC of 26 June 1990 on expenditure in the veterinary field (1), as last amended by Regulation (EC) No 1258/1999 (2), and in particular Article 14 thereof, (1) Whereas, by virtue of Council Decision 91/666/EEC of 11 December 1991 establishing Community reserves of foot-and-mouth disease vaccines (3), establishment of antigen banks is part of the Community's action to create Community reserves of foot-and-mouth disease vaccine; (2) Whereas Article 3 of that Decision designates the ‘Labo- ratoire de pathologie bovine du Centre national d'études vétérinaires et alimentaires’ at Lyon in France, the ‘Isti- tuto Zooprofilattico Sperimentale di Brescia’ in Italy and the ‘Institute for Animal Health’ at Pirbright in the United Kingdom as antigen banks holding Community reserves; (3) Whereas the functions and duties of these antigen banks are specified in Article 4 of that Decision; whereas Community assistance must be conditional on accom- plishment of these; (4) Whereas Community financial assistance should be granted to these banks to enable them to carry out during 1999 the said functions and duties; (5) Whereas for budgetary reasons the Community assis- tance should be granted for a period of one year; (6) Whereas for supervisory purposes Articles 8 and 9 of Council Regulation (EEC) No 729/70 of 21 April 1970 on financing of the common agricultural policy (4), as last amended by Regulation (EC) No 1287/95 (5), should apply; (7) Whereas the measures provided for in this Decision are in accordance with the opinion of the Standing Veter- inary Committee, (1) OJ L 224, 18. 8. 1990, p. 19. (2) OJ L 160, 26. 6. 1999, p. 103. (3) OJ L 368, 31. 12. 1991, p. 21. (4) OJ L 94, 28. 4. 1970, p. 13. (5) OJ L 125, 8. 6. 1995, p. 1. Article 1 The Community shall grant France financial assistance for foot-and-mouth 1. the stocking of antigen for production of disease vaccine. 2. The ‘Laboratoire de pathologie bovine du Centre national d'études vétérinaires et alimentaires’ at Lyon in France shall hold the stock of antigen to which paragraph 1 relates. The provisions of Article 4 of Decision 91/666/EEC shall apply. The Community's 3. a financial maximum of EUR 40 000 for the period 1 January to 31 December 1999. assistance shall be Article 2 The Community shall grant Italy financial assistance for foot-and-mouth 1. the stocking of antigen for production of disease vaccine. 2. in The ‘Istituto Zooprofilattico Sperimentale di Brescia’ Italy shall hold the stock of antigen to which paragraph 1 relates. The provisions of Article 4 of Decision 91/666/EEC shall apply. The Community's a financial 3. maximum of EUR 40 000 for the period 1 January to 31 December 1999. assistance shall be Article 3 The Community shall grant the United Kingdom financial the stocking of antigen for production of 1. assistance for foot-and-mouth disease vaccine. 2. The Institute for Animal Health at Pirbright in the United Kingdom shall hold the stock of antigen to which paragraph 1 relates. The provisions of Article 4 of Decision 91/666/EEC shall apply. The Community's 3. a financial maximum of EUR 20 000 for the period 1 January to 31 December 1999. assistance shall be 21. 8. 1999 EN Official Journal of the European Communities L 221/13 Article 4 Article 5 The Community's financial assistance referred to in 1. Article 1(3), Article 2(3) and Article 3(3) of the present Decision shall be paid, following presentation, by the Member State concerned, of supporting documents which demonstrate the effective completion of the tasks. 2. The supporting documents referred to in paragraph 1 must be presented to the Commission before 1 March 2000 and they should include: (a) technical information on: — the amount and type of antigen stored (storage records), — storage equipment used (type, number and capacity of tanks), — security system in place (temperature control, anti-theft measures), — insurance arrangements (fire, accidents); (b) financial information (completion of table as shown in the Annex). Articles 8 and 9 of Regulation (EEC) No 729/70 shall apply mutatis mutandis. Article 6 This Decision is addressed to the French Republic, the Italian Republic and the United Kingdom of Great Britain and Northern Ireland. Done at Brussels, 28 July 1999. For the Commission Franz FISCHLER Member of the Commission L 221/14 EN Official Journal of the European Communities 21. 8. 1999 ANNEX Financial information related to the storage of antigen for production of foot-and-mouth disease vaccine STATEMENT OF COSTS Reporting period: from. to. Reference number of Commission Decision providing financial assistance:. Name and address of beneficiary:. Category of costs Amount for the period (National currency) (1) 1. Staff 2. Capital equipment 3. Consumables 4. Insurance 5. Rental of premises (1) All costs must be expressed in national currency. Total Certificate by the beneficiary We certify that: — the above costs were incurred in connection with the tasks defined in the Decision and were essential to the sound performance of those tasks, — they are genuine costs falling within the definition of reimbursable costs, — all the documents supporting the costs are available for audit purposes. Date:. Name of technical director:. Signature:. Date:. Person financially responsible:. Signature: